Trial intelligence / Profile preview

Pharmacokinetics of atazanavir boosted with ritonavir during pregnancy and postpartum

2005-004809-29Phase 3Active

Sponsor
Papa Giovanni XXIII Hospital
Start
Sep 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label, single-arm trial of atazanavir and ritonavir in human immunodeficiency virus infection (HIV), sponsored by Papa Giovanni XXIII Hospital. Primary endpoint: Primary pharmacokinetic parameters of atazanavir and ritonavir. Started Sep 2007; status: active.

02

Drugs

atazanavirritonavir
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on 2005-004809-29.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-004809-29.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call